United States· US:58844-130_4b196948-f481-3bd6-e063-6394a90aaae1
Macrilen
A macimorelin product containing macimorelin, registered in United States by Aeterna Zentaris GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Macimorelin is registered in 12 of 19 countries.
Countries holding a registration under ATC V04CD06 (macimorelin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Macimorelin · ATC V04CD06
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MACIMORELIN
- Manufacturer
- Aeterna Zentaris GmbH
- Country
- United States (US)
- ATC code
- V04CD06
- ATC class
- Macimorelin
- Defined daily dose
- 35 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1158844130011 POUCH in 1 CARTON (58844-130-01) / 60 mg in 1 POUCH
- ndc1158844-130-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
398 interactions on record for macimorelin.
Graded by severity as the source publishes them — 241 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Macimorelin · interactions on record
398 records
- 241 severe
- 154 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Macimorelin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGhryvelin 60mg granules for oral suspension sachetsConsilient Health Ltd
- CzechiaGHRYVELINAtnahs Pharma Netherlands B.V., Amsterdam
- SpainGHRYVELIN 60 MG GRANULADO PARA SUSPENSIÓN ORAL EN SOBREAtnahs Pharma Netherlands Bv.
- FinlandGHRYVELINAtnahs Pharma Netherlands B.V.
- FranceGHRYVELIN 60 mg granulés pour suspension buvable en sachetATNAHS PHARMA NETHERLANDS (PAYS-BAS)
- IrelandGHRYVELIN 60 mg granules for oral suspension in sachetAtnahs Pharma Netherlands B.V.
- IcelandGHRYVELINAtnahs Pharma Netherlands B.V.
- NetherlandsGHRYVELIN 60 mg granulaat voor orale suspensie in sachetAtnahs Pharma Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- United Kingdom (Northern Ireland) · Macimorelin Atnahs Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/638d6f75-57db-442a-a061-575356f88b00 GET /v1/drugs/638d6f75-57db-442a-a061-575356f88b00?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "60",
"substance": "MACIMORELIN",
"productndc": "58844-130",
"dosage_form": "GRANULE, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/1817mg",
"application_number": "NDA205598",
"marketing_category": "NDA"
}See everything about macimorelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.